Search Immortality Topics: | |
Home » Global News Feed » AB Science receives first agencies authorizations to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer’s…
AB Science receives first agencies authorizations to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer’s…
Posted: October 11, 2022 at 2:07 am